Spot Trading’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Spot Trading’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-663	Closed	-$35K	–	4233
2016 Q1	$35K	Sell	663 -300	-31%	-$22.1K	﹤0.01%	2910
2015 Q4	$109K	Sell	963 -1,707	-64%	-$188K	﹤0.01%	2769
2015 Q3	$314K	Sell	2,670 -18,370	-87%	-$2.4M	﹤0.01%	2374
2015 Q2	$1.63M	Buy	21,040 +5,324	+34%	+$349K	0.01%	1274
2015 Q1	$909K	Buy	+15,716	New	+$667K	0.01%	1673

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Spot Trading's ANAC Position: Q2 2016 in Review

Spot Trading sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 663 shares — an estimated $35K sold.

Spot Trading first reported a position in ANAC in Q1 2015 and held it in 5 quarters. The position peaked at $1.63M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Spot Trading reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Spot Trading sold 663 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $35K.
Spot Trading first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
Spot Trading's ANACOR PHARMACEUTICALS INC COM position peaked at $1.63M in Q2 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.